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SUMMARY – The National Center for Complementary and Alternative Medicine defines com-
plementary and alternative medicine as a group of diverse medical and health care systems, practices 
and products that are not generally considered part of conventional medicine. Multiple sclerosis 
(MS) is a chronic disabling disease of the central nervous system that affects people during early 
adulthood. In spite of many approved medications, the treatment options in MS are limited. Many 
people with MS explore complementary and alternative medicine (CAM) treatments to help control 
their MS and treat their symptoms. Surveys suggest that up to 70% of people with MS have tried 
one or more CAM treatment for their MS. People with MS using CAM generally report deriving 
some benefit from therapies. The CAM therapies most frequently used include diet, omega-3 fatty 
acids and antioxidants. The therapies with highest potential among CAM therapies that warrant 
further investigation are low-fat diet, omega-3 fatty acids, lipoic acid, and vitamin D supplemen-
tation as potential anti-inflammatory and neuroprotective agents in both relapsing and progressive 
forms of MS. There are very limited researches evaluating the safety and efficacy of CAM in MS. 
However, in recent years, the USA National Institutes of Health and the National Multiple Sclero-
sis Society have been actively supporting the researches in this very important area.
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Introduction
The USA National Center for Complemen-
tary and Alternative Medicine (NCCAM) defines 
complementary and alternative medicine as a group 
of different medical and health care systems, prac-
tices and products that are not generally considered 
part of conventional medicine. This is a large group 
of therapeutic and diagnostic disciplines that exist 
outside conventional health care institutions1. The 
boundaries between complementary and alternative 
medicine (CAM) and conventional medicine (West-
ern or allopathic medicine) are not always sharp or 
fixed, and specific CAM practices may become widely 
accepted2. The term ‘complementary medicine’ refers 
to therapeutic disciplines that are used together with 
conventional medicine, such as using acupuncture in 
addition to usual care for helping in the treatment of 
different pain syndromes. The other part of the term 
CAM is ‘alternative medicine’, which refers to the use 
of CAM in place of conventional medicine1.
Multiple sclerosis (MS) is a chronic disabling 
disease of the central nervous system (CNS). Most 
patients initially have a form of MS referred to as 
relapsing-remitting MS (RRMS). This type of MS 
is characterized by periods of clinical stability that 
are interrupted by relapses or attacks of MS during 
Acta Clin Croat,  Vol. 52,  No. 4,  2013 465
Vanja Bašić Kes et al. The role of complementary and alternative medicine in therapy of multiple sclerosis
which patients experience clinical worsening. Patients 
may or may not have complete recovery from these 
relapses. Approximately 50% of patients with RRMS 
eventually enter a phase of the illness referred to as 
secondary progressive MS (SPMS), in which there is 
progressive worsening of their disease. Patients with 
SPMS often cease to have clinical relapses of MS. 
Approximately 10%-15% of people with MS have pri-
mary progressive MS (PPMS), in which there is pro-
gressive worsening of the neurologic symptoms from 
the onset of disease. Multiple sclerosis pathogenesis 
is believed to involve an autoimmune response within 
the CNS, resulting in multifocal demyelination with 
varying axonal injury. Treatments for MS are divided 
into two large categories: those that are intended to 
control the disease process (human recombinant in-
terferon (IFN)-β, glatiramer acetate, natalizumab 
and mitoxantrone) and those that help manage the 
symptoms, which most often include fatigue, depres-
sion, cognitive impairment, spasticity, pain and im-
balance that can have a significant negative impact 
on the patient’s quality of life; hence, treatment tar-
geting these is critical. Because of the desire to use 
holistic health care, patient empowerment, improving 
general health, and relief from physical and psycho-
logical symptoms, the majority of MS patients (up to 
70%) use CAM as an adjunct to conventional thera-
pies rather than as an alternative to conventional MS 
therapies, and perceive both conventional and CAM 
therapies as being beneficial. However, there is always 
the danger of using some expensive CAM therapies 
that have no clear benefit or that may even potentially 
have some toxic effects3.
Classification of Complementary and Alternative 
Medicine
NCCAM has developed one of the most widely 
used classification systems of CAM into five major 
groups. Although these categories are not formally 
defined, they are useful for discussing CAM prac-
tices4. 
1. Whole medical systems, which are complete sys-
tems of theory and practice that have evolved over 
time in different cultures and apart from conven-
tional Medicine; examples include Traditional 
Chinese medicine, Naturopathy, Homeopathy and 
Ayurveda.
2. Mind-body medicine is focused on the intercon-
nection between the mind, body, and spirit. It 
works under the premise that the mind can affect 
“bodily functions and symptoms”; examples in-
clude meditation, yoga, acupuncture, deep-breath-
ing exercises, guided imagery, hypnotherapy, pro-
gressive relaxation, qi gong and tai chi.
3. Biology-based practices use substances found in 
nature such as herbs, foods, vitamins, and other 
natural substances. Many are sold over-the-coun-
ter as dietary supplements. CAM ‘natural prod-
ucts’ include probiotics.
4. Manipulative and body-based practices feature 
manipulation or movement of body parts, such as 
is done in chiropractic and osteopathic manipula-
tion.
5. Energy medicine is a domain that deals with puta-
tive and verifiable energy fields: 
•	 Biofield	therapies	are	intended	to	influence	en-
ergy fields that, it is purported, surround and 
penetrate the body. No empirical evidence has 
been found to support the existence of the puta-
tive energy fields on which these therapies are 
predicated.
•	 Bioelectromagnetic-based	 therapies	 use	 verifi-
able electromagnetic fields, such as pulsed fields, 
alternating current, or direct-current fields in an 
unconventional manner1,5
Acupuncture, Chinese Herbal Medicine, and 
Traditional Chinese Medicine
Acupuncture is one component of the ancient 
multimodal therapeutic approach known as Tradi-
tional Chinese Medicine (TCM). Other TCM com-
ponents include herbs, nutrition, exercise, tai chi, 
stress reduction, and massage5. Studies of TCM are 
surprisingly limited. Clinical trials of acupuncture 
for treating symptoms in patients with MS are too 
limited to provide definitive information6. In other 
conditions, acupuncture appears to alleviate pain as 
well as nausea and vomiting. No rigorous studies of 
Chinese herbal medicine in MS are available7. When 
performed by a well-trained practitioner, acupuncture 
is generally well tolerated. In contrast, Chinese herb-
al medicine is of unknown safety for many medical 
conditions including MS. Activation of the immune 
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system, a theoretical risk for worsening MS antago-
nizing the therapeutic effects of immune-modulating 
and immune-suppressing medications, may be caused 
by multiple Chinese herbs, including Asian ginseng, 
astragalus, and maitake and reishi mushrooms4,8,9. 
Acupuncture as a low risk and moderately expensive 
component of TCM in MS treatment is not well stud-
ied, but based on other studies it may alleviate pain. 
In contrast, Chinese herbal therapy, also a moderately 
expensive therapy, is of unknown efficacy, its use poses 
a theoretical risk and should probably be avoided.
Bee Venom Therapy
Bee venom therapy is carried out by placing bees 
on specific body parts with tweezers. The aim is to ac-
complish a bee sting. The highest quality clinical trial 
of bee venom therapy in MS was a randomized cross-
over study in 26 patients with relapsing-remitting or 
secondary progressive MS10. This study showed that 
bee venom therapy did not produce any beneficial ef-
fects regarding MS activity, attack frequency, neuro-
logic disability, fatigue, and overall quality of life. As 
a therapeutic method, it is a well-tolerated method 
with imperceptible eventuality of anaphylaxis. More-
over, bee stings around the eye, which are sometimes 
claimed to relieve MS-related visual problems, should 
be avoided because they may actually cause optic neu-
ritis11. Bee venom therapy, a low to moderate cost and 
generally safe therapy, is ineffective therapy in the 
treatment of patients with MS12.
Dietary Supplements 
Antioxidants
Because of the assumption that free radical-in-
duced oxidative damage may play a role in myelin and 
axonal injury in MS, it is sometimes claimed that an-
tioxidants should be used as the treatment of patients 
with MS. Many antioxidant compounds activate T 
cells, macrophages and other immune cells, thus they 
pose theoretical risks in MS. However, in experimen-
tal allergic encephalomyelitis, multiple antioxidant 
compounds have produced therapeutic effects13,14. 
Small short-term MS clinical trials with various an-
tioxidants such as inosine15, alpha-lipoic acid16, and a 
combination of selenium and vitamins C and E17 in-
dicate that these approaches are well tolerated. Un-
til now, there are no quality studies that could with 
certainty provide evidence for the efficacy of antioxi-
dant therapy in the treatment of MS patients. Hence, 
antioxidants represent an inexpensive means of MS 
treatment with possible, but also not fully proved, 
therapeutic effects.
Cranberry
An MS-associated bladder dysfunction can fre-
quently cause urinary tract infection (UTI). Cran-
berry may prevent UTI through a novel mechanism 
of action in which herb constituents inhibit bacterial 
adhesion to the uroepithelium9. Multiple studies in-
dicate that cranberry may prevent UTI, but there is 
no evidence that cranberry should be used for treat-
ing UTI18. It is important to accentuate that UTI may 
cause pseudoexacerbations that should be recognized 
by clinicians and promptly treated with antibiotics 
and not cranberries. Cranberry is a low-risk, inexpen-
sive and generally well tolerated therapy, except for 
the fact that it may increase the anticoagulant effect 
of warfarin and in long-term use it may increase the 
risk of kidney stones. It should only be used to prevent 
and not to treat UTI.
Echinacea, ginseng and other ‘ immune-stimulating’ 
supplements
Echinacea, alfalfa, ashwagandha (Withania som-
nifera), ginseng, astragalus, cat’s claw, garlic, maitake 
and shiitake mushrooms, mistletoe, stinging nettle, 
melatonin and zinc19 are the supplements the effects 
of which on the activation of T cells or macrophages 
were only studied in vitro or on animal models. Gin-
seng is one of the most extensively studied herbal 
products in the scientific literature20. The known ac-
tive constituents of Asian ginseng are the ginsenosides 
with an antioxidant activity and many other effects. 
Despite uncertainty about its mechanism of action, a 
limited number of placebo-controlled trials have sug-
gested that ginseng is capable of decreasing fatigue in 
MS patients. Immune-stimulating supplements pose 
theoretical risk in MS. Although ginseng extracts ap-
pear to be safe, large doses can cause side effects such 
as hypertension, nervousness, irritability, insomnia, 
rash and diarrhea. Five different animal models using 
conventional toxicological methods report no acute or 
chronic toxicity of the extract21. Echinacea may also 
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increase the hepatotoxicity of medications, which in-
clude some MS medications such as interferons and 
methotrexate19.
Ginkgo biloba
Ginkgo biloba, derived from the leaf of the Gink-
go biloba tree, is also one of the traditional Chinese 
medicine treatments that have been used for centuries 
in China. It could have not only symptomatic but also 
disease-modifying effects in MS because of its anti-
inflammatory and antioxidant effects. Some studies in 
experimental allergic encephalomyelitis indicate that 
ginkgo decreases disease severity16. In small clinical 
trials in MS, ginkgo improved cognition22 and fa-
tigue23, but it does not appear to be effective for treat-
ing MS attacks24. Ginkgo is generally well tolerated 
but since it has anticoagulant effects and may rarely 
provoke seizures, it should be avoided or used with 
vigilance by patients with seizures and those who take 
antiplatelet or anticoagulant medications, are under-
going surgery, or have coagulopathies. It can also 
cause dizziness, headaches, rashes, nausea, vomiting, 
diarrhea, and flatulence25. It is an inexpensive therapy 
that possibly may improve fatigue and cognitive dys-
function. 
St. John’s wort 
In the past, St. John’s wort was used to treat depres-
sion, which is a very usual MS symptom. It appears 
to be effective for the treatment of mild-moderate, 
but not severe depression. St. John’s wort may cause 
fatigue, photosensitivity, and may alter the levels of 
many medications including anticonvulsants, warfa-
rin (Coumadin), antidepressants and oral contracep-
tives. It is usually an inexpensive and well tolerated 
herb25,26.
Vitamin B12
It is sometimes claimed that vitamin B12 supple-
ments are an effective MS therapy5. There is no evi-
dence demonstrating that vitamin B12 supplements 
provide clinically significant therapeutic effects to pa-
tients with MS generally27. A small subset of patients 
with MS that have vitamin B12 deficiency require vi-
tamin B12 supplementation. Vitamin B12 supplementa-
tions, administered intramuscularly or orally, are gen-
erally safe, inexpensive and well tolerated. They rarely 
cause rashes, itching and diarrhea25.
Vitamin D
Vitamin D is a group of fat-soluble prohormones, 
the two major forms of which are vitamin D2 (or 
ergocalciferol) and vitamin D3 (or cholecalciferol). 
Since the MS patients are at risk of developing os-
teopenia and osteoporosis, vitamin D is important for 
maintaining bone density28. Also, since vitamin D has 
an important immune-regulating role, it could exert 
disease-modifying effects in MS29. Some studies in-
dicate that low vitamin D levels and low vitamin D 
intake are associated with an increased risk of devel-
oping MS30. Definitive well-designed trials of vita-
min D supplementation as a preventive remedy in MS 
have not been reported. Vitamin D is a low-cost and 
generally well-tolerated therapy. In high doses, it may 
cause fatigue, abdominal cramps, nausea, vomiting, 
renal damage, hypertension, and other side effects. 
The tolerable upper intake level of vitamin D is 2000 
international units (IU) daily. The adequate intake of 
vitamin D is 200 to 600 IU daily25.
Diet
Swank diet and other diets enriched with 
polyunsaturated fatty acids
The most often used CAM therapies among MS 
patients include diet and omega-3 fatty acids (FAs). 
They may have potential benefit in MS as they have 
immunomodulatory and neuroprotective properties 
when evaluated in animal models, as well as in MS 
patients and in other chronic disease conditions. They 
also appear to have a high safety profile when used at 
recommended doses.
Swank and Dugan dietary strategy is based on low 
intake of saturated fat. On the basis of clinical trial, 
this strategy has been reported to have therapeutic ef-
fects in MS, but the trial was not controlled, blinded, 
or randomized31.
Omega-3 FAs and omega-6 FAs are a family of 
polyunsaturated FAs (PUFAs). Three randomized 
controlled trials studied the use of omega-6 supple-
ments. Two of these trials found a statistically sig-
nificant reduction in MS attack severity and duration. 
Data from all three trials demonstrated therapeutic 
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effects on disability progression in subjects with mild 
MS at the start of the trial32. The most rigorous in-
vestigation of omega-3 supplementations in MS was 
a large, randomized, double-blind, controlled trial 
that did not find a statistically significant treatment 
effect33. One small randomized trial of omega-3 FA 
supplements in combination with glatiramer acetate 
or interferons reports a trend of improved physical 
and emotional functioning in study subjects taking 
omega-3 FAs34. Preparations of fish oil, a rich source 
of omega-3 FAs, are generally well tolerated and safe. 
However, the safety of long-term supplementation 
with other omega-3 FAs and all omega-6 FAs is not 
known. Omega-6 FAs may elevate triglyceride levels 
and may rarely provoke seizures. Some omega-3 and 
omega-6 FAs may have mild anticoagulant effects. 
Also, supplementation with PUFAs may cause vita-
min E deficiency. Thus, supplementation of vitamin D 
may be necessary25. Although these dietary approach-
es have produced suggestive results in MS clinical tri-
als, they should not be used instead of conventional 
disease-modifying medications.
Hyperbaric Oxygen 
Hyperbaric oxygen (HBO) has a reputation as an 
effective treatment for many diseases including MS. In 
practice, however, it is approved only for the treatment 
of burns, severe infections, carbon monoxide poison-
ing, and decompression sickness. Multiple subsequent 
studies did not generally find significant therapeutic 
effects. Although HBO is usually well tolerated, it 
may produce mild visual symptoms and some rare ad-
verse effects like cataracts, seizures, pressure injury to 
the ear, and pneumothorax6. Because of its high cost 
and no therapeutic effects in MS, at this time, routine 
treatment of MS with HBO is not recommended35.
Low Dose Naltrexone
In MS, there have been statements that low oral 
doses of naltrexone (LDN), which is an opiate antag-
onist, alleviate symptoms, prevent attacks, and slow 
down disability progression. However, there are no 
quality studies to support such statements. Prelimi-
nary report of an 8-week study in 80 patients with 
relapsing or progressive MS states that LDN had no 
effect on physical functioning but it had some favor-
able effects on pain and mental health36. Another 
6-month open-label study of LDN in 40 people with 
primary progressive MS found that its use improved 
spasticity, worsened pain, and had no effects on fa-
tigue, depression and overall quality of life37. LDN is 
moderately expensive and generally well tolerated, but 
further studies are needed to determine with certainty 
its effectiveness in MS.
Cannabis (Marijuana)
The majority of controlled studies have evalu-
ated cannabinoids for spasticity in MS. The ma-
jor psychoactive constituent in cannabis is δ-9-
tetrahydrocannabinol (THC). Cannabidol (CBD) 
is a non-psychoactive constituent in cannabis and is 
the major constituent in the plant. It is thought to de-
crease the clearance of THC by affecting liver me-
tabolism. In a review of six controlled studies evaluat-
ing a combination of THC and CBD for spasticity in 
MS, it was found that THC-CBD was well tolerated 
and improved patient self-reports of spasticity. Objec-
tive measures did not show significant improvement 
compared with placebo38. Several studies of variable 
quality showed that Sativex (an oral form of canna-
bis) relieved pain, spasticity and sleeping difficulties39. 
Marijuana has many possible side effects such as seda-
tion, seizures, nausea, vomiting, incoordination, poor 
pregnancy outcomes, impaired lung function, and 
increased risk of cancer of the head, neck and lung8. 
Besides, it is illegal in many countries.
Tai Chi
Tai chi as part of the TCM has been practiced for 
centuries in China. Multiple sclerosis as a disease of the 
CNS40 through various symptoms has negative effects 
on the MS patients’ quality of life. Small non-blinded 
trials of tai chi in MS have displayed suggestive thera-
peutic effects on spasticity, walking, and social and 
emotional functioning, in one word, on the quality of 
life41. Tai chi is a low-moderate cost and generally safe 
therapy. Because of the risk of falling, straining joints 
and muscles, it should be modified or avoided by those 
patients who have severe osteoporosis, bone fractures, 
acute low back pain, and joint injuries5.
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Yoga
Yoga implies a widely prevailing practice of physi-
cal postures or poses that were developed in India 
thousands years ago. One randomized controlled trial 
emphasized that patients who practiced yoga or did 
conventional exercise experienced significantly less fa-
tigue42. Yoga is generally well tolerated, but it should 
be modified or avoided by pregnant women and those 
patients with gait instability, fatigue, heat sensitivity, 
or significant lung, heart or bone failures9.
Conclusion
The use of CAM, in addition to conventional 
medical treatments, for treating such a complex dis-
ease requests careful consideration. The well-designed 
clinical studies of many CAM therapies are often 
lacking, therefore the safety and effectiveness of many 
CAM therapies are uncertain. Within the context 
of MS, some therapies may possibly be helpful, and 
some of them are poorly studied, potentially malefi-
cent or inefficient. Patients often use many therapeutic 
methods and supplements from the domain of CAM. 
However, their knowledge about the efficacy and side 
effects of those therapies is insufficient. So, it is impor-
tant that neurologists and other conventional health 
professionals have sufficient knowledge of the CAM 
topic, so they could have a positive participating role 
in the care and treatment of patients with MS by dif-
ferentiating CAM therapies that may have reasonable 
efficacy-safety profiles from those that are unstudied, 
ineffective and dangerous. 
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Sažetak
ULOGA KOMPLEMENTARNE I ALTERNATIVNE MEDICINE U TERAPIJI MULTIPLE SKLEROZE
V. Bašić Kes, M. Cesarik, L. Zadro Matovina, I. Zavoreo, L. Ćorić, S. Drnasin i V. Demarin
Nacionalni centar za komplementarnu i alternativnu medicinu u Sjedinjenim Američkim Državama definira kom-
plementarnu i alternativnu medicinu kao skupinu različitih medicinskih i zdravstvenih sustava, praksa i proizvoda koji se 
općenito ne smatraju dijelom konvencionalne medicine. Multipla skleroza je kronična onemogućavajuća bolest središnjeg 
živčanog sustava koja se javlja u mlađoj odrasloj dobi. Unatoč mnogim istraženim i odobrenim lijekovima mogućnosti 
liječenja multiple skleroze su ipak ograničene. Zbog toga mnogi bolesnici koji boluju od multiple skleroze istražuju djelo-
vanja metoda iz okvira komplementarne i alternativne medicine ne bi li postigli bolju kontrolu bolesti te smanjili simptome 
iste. Istraživanja ukazuju na to da je do 70% bolesnika oboljelih od multiple skleroze u tijeku liječenja bolesti isprobalo 
jednu ili više metoda iz okvira komplementarne i alternativne medicine. Većina oboljelih od multiple skleroze koji su 
koristili metode komplementarne i alternativne medicine navodi da su iskusili neke povoljne učinke. Najčešće korištene 
metode komplementarne i alternativne medicine su dijeta, omega-3 masne kiseline i antioksidansi. Među metode koje bi 
mogle imati najviše potencijala u terapiji multiple skleroze, a za koje su potrebna daljnja istraživanja, ubrajaju se dijeta s 
malim udjelom masnoće, omega-3 masne kiseline, lipoična kiselina i nadomjesci vitamina D kao sredstva s protuupalnim 
i neuroprotektivnim djelovanjem kako u relapsnom, tako i u progresivnom obliku multiple skleroze. Dosad je provedeno 
nedovoljno istraživanja koja su za cilj imala procjenu sigurnosti i učinkovitosti komplementarne i alternativne medicine u 
liječenju multiple skleroze. Upravo zbog toga posljednjih nekoliko godina Nacionalno društvo za multiplu sklerozu aktiv-
no podupire istraživanja u ovom vrlo važnom području.
Ključne riječi: Antioksidansi; Komplementarne terapije; Prehrambeni dodaci; Masne kiseline, esencijalne; Dijeta sa smanjenim 
udjelom masnoća; Multipla skleroza
